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This cohort study assesses the association between psychosis in elderly patients with Alzheimer disease
and social cognition in a longitudinal study.
Symptoms of psychosis in patients with Alzheimer disease may be the expression of a pathological
subtype associated with an accelerated cognitive and functional deterioration portending a hastened
mortality.1 The proposed National Institute of Mental Health Research Domain Criteria initiative provides
a framework for conceptualizing the common neurobiological underpinnings of symptom domains such as
psychosis that transcend individual diagnostic categories to facilitate translational research.2 Gur et al3
suggest that highly implementable tasks measuring facial affective processing can be used to assay social
cognitive integrity in psychotic disorders within the National Institute of Mental Health Research Domain
Criteria framework. Although McLellan et al4 report that facial affective processing is degraded in
Alzheimer disease, to our knowledge no published studies have investigated the association between this
impairment and the psychotic phenotype. We report on facial affective processing performance in a
longitudinal cohort of healthy elderly control individuals and participants with mild cognitive impairment
(MCI) or Alzheimer disease at baseline, with and without symptoms of psychosis over the course of the
study.

Methods
Participants were recruited from Long Island and from the New York metropolitan area, in response to
community outreach and direct referral by neurologists, psychiatrists, and geriatricians, for a longitudinal
study investigating biomarkers of dementia. The study was approved by the institutional review board of
the Northwell Health System and written informed consent was obtained. Assessments included the MiniMental State Examination (MMSE), the Comprehensive Affective Testing System Identity Discrimination
and Name Affect subtasks, and the Neuropsychiatric Inventory psychosis subscales. The 92 recruited
participants were followed up annually for up to 6 years. Psychotic symptoms in Alzheimer disease are a
common but not ubiquitous manifestation of the disease, occurring in 30% to 40% of individuals over the
course of the illness.1 The 92 recruited participants were followed annually for up to 6 years, and divided
into cohorts depending on whether psychotic symptoms emerged. For analysis, the cohort was divided into
3 diagnostic groups: participants with MCI or Alzheimer disease at baseline who would not become
psychotic during the study (n = 38), participants with MCI or Alzheimer disease at baseline who would
become psychotic during the study (n = 18), and cognitively healthy elderly controls (n = 36). Mixed
model repeated measures analysis of variance used to determine if Comprehensive Affective Testing
System performance differed across groups after adjustment for covariates (sex, age, group, educational
level, MMSE score, and time [number of annual assessments]) (SAS, version 9.4; SAS Institute Inc).

Results
Of the 92 study participants (mean [SD] age 72.23 [11.2]), 50 were female (54%) (Table 1). On the Name
Affect task, after adjustment for covariates, group differences in performance between impaired and
nonimpaired groups were significant in the mixed model repeated measures analysis of variance (F2163 =
3.42; P = .03). Direct comparisons revealed that after adjustment for covariates including MMSE score, the
presence of psychosis was associated with poorer performance when compared with the group without
psychosis (change in score, −1.28 [95% CI, −2.57 to 0.007]; P = .05) and with the control group (change in
score, −1.79 [95% CI, −3.16 to −0.42]; P = .01) (Table 2). In the unadjusted model, the group without
psychosis differed from controls (change in score, −0.74 [95% CI, −1.43 to −0.05]; P = .03), but not
significantly following adjustment for covariates (Table 2). MMSE score was independently associated
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with performance on the Name Affect task across groups such that for each additional MMSE point there
was an approximate increase of 0.11 (95% CI, 0.02-0.19; P = .01) score on Name Affect. As impaired
affect recognition was associated with psychosis after adjustment for covariates, and as MMSE score was
orthogonally associated with performance on the task, this suggests an association with the psychotic
phenotype while highlighting the cognitive integrity required for adequate task performance.
On the Identity Discrimination task, after adjustment for covariates, with each year of additional age there
was an approximate −0.03 ([95% CI, −0.06 to −0.01]; P = .01) reduction in score. Male sex was associated
with poorer performance (change in score, −0.70 [95% CI, −1.3 to −0.1]; P = .02) on the task. MMSE
score was also associated with performance with an approximate 0.22 (95% CI, 0.15-0.30; P < .001)
increase in score for each additional MMSE point. In the unadjusted model, the psychotic group differed
from controls (change in score, −2.70 [95% CI, −3.70 to −1.70]; P < .001) but this difference was not
significant after adjustment for MMSE.

Discussion
Evidence suggests that impairments of facial affective processing are a feature of psychotic illnesses,
including schizophrenia and bipolar disorder.5,6 Deficits of affect recognition in a population with
cognitive impairment may predispose such individuals to the erroneous decoding of the social signals of
others, leading to delusional misinterpretations. Alternatively, the pathologic process responsible for the
accelerated decline of individuals with Alzheimer disease and symptoms of psychosis may affect social
neural networks recruited in affect recognition. In this sample the ability to discriminate faces–to
determine whether 2 pictures show the same or different faces–was most closely associated with cognitive
integrity as estimated with an MMSE score. The finding suggests that, in Alzheimer disease, networks
responsible for facial identification may be more closely related to nonsocial cognitive or visuoperceptual
domains. A limitation of this study is the number of patients with Alzheimer disease and psychosis.
However, these data support the transdiagnostic relevance of social cognition in psychotic syndromes
conceptualized within the National Institute of Mental Health Research Domain Criteria framework.
Currently, the development of preclinical models of psychosis relies on a short list of behavioral paradigms
with cross-species relevance, among them locomotor hyperactivity and disruption of sensorimotor gating.1
Expanding this list to include social cognitive outcomes- paradigms that can be employed in murine
models in the form of social learning and memory- may promote translational research and antipsychotic
drug development.
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Table 1.
Baseline Covariates
Variable

Group
MCI/AD (n = 38) MCI/AD+P (n = 18) HEC (n = 36)

Female, No. (%)

21 (57)

10 (56)

19 (53)

Age, mean (SD), y

72.3 (9.1)

75.8 (10)

70.5 (13.3)

Educational attainment, mean (SD), y 15.5 (3.5)
a
MMSE score, mean (SD)
24.7 (3.3)

15.7 (3.1)

16.4 (2.9)

20.2 (5.9)

28.9 (1.3)

Abbreviations: HEC, healthy elderly controls; MCI/AD, mild cognitive impairment or Alzheimer disease;
MCI/AD+P, psychosis in MCI or AD; MMSE, Mini-Mental State Examination.
a

P < .001 for the difference in scores among the 3 groups.
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Table 2.
Fixed Effects for Identity Discrimination, Name Affect, and MMSEa
Group

Change in Score (95% CI) P Value

Unadjusted Fixed Effects
Identity discrimination
MCI/AD vs HEC

−0.53 (−1.13 to 0.07)

.08

MCI/AD+P vs HEC

−2.70 (−3.70 to −1.70)

<.001

MCI/AD vs HEC

−0.74 (−1.43 to −0.05)

.03

MCI/AD+P vs HEC

−2.61 (−3.87 to −1.35)

<.001

Age

−0.03 (−0.06 to −0.01)

.01

Male

−0.70 (−1.3 to −0.10)

.02

MMSE

0.22 (0.15 to 0.30)

<.001

MCI/AD+P vs HEC

−1.79 (−3.16 to −0.42)

.01

MCI/AD+P vs AD

−1.28 (−2.57 to 0.007)

.05

MMSE

0.11 (0.02 to 0.19)

.01

Name affect

Adjusted Fixed Effects
b
Identity discrimination

c
Name affect

Abbreviations: HEC, healthy elderly controls; MCI/AD, mild cognitive impairment or Alzheimer disease;
MCI/AD+P, psychosis in MCI or AD; MMSE, Mini-Mental State Examination.
a

Results of repeated measures analysis of variance to determine if Comprehensive Affective Testing System Identity
Discrimination and Name Affect subtasks scores differed over time across groups of HEC, patients with MCI or AD
without psychosis, and patients with MCI or AD +P after adjustment for covariates (sex to age to group to education
to MMSE and to time [number of annual assessments]).
b
For age the estimates reflect change in score with additional year of age; for MMSE the estimates reflect change in
score for each additional 1-point increase in MMSE.
c
For MMSE, the estimates reflect change in score for each additional 1-point increase in MMSE.
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